Navigation Links
Aware, Inc. Joins HIMSS10 Interoperability Showcase to Demonstrate Standards-Based Medical Image Sharing

BEDFORD, Mass., Feb. 25 /PRNewswire-FirstCall/ -- Aware, Inc. (Nasdaq: AWRE), a global provider of imaging and biometrics software, today announced it will demonstrate standards compliance and interoperability of its medical image sharing products as a participant in the HIMSS10 Interoperability Showcase.  The Showcase is part of the HIMSS10 Annual Conference & Exhibition taking place in Atlanta from March 1-4, 2010.

Aware will demonstrate its AccuRad ImageShare™ Platform, a standards-based solution for fast and efficient compression, streaming, and viewing of images in electronic health records (EHR) in cross-enterprise health information exchange (HIE) systems. Its client and server components enable users with fast access to diagnostic-quality images across multiple enterprises over constrained networks.

"Participating in the showcase allows us an opportunity to demonstrate the compliance and functionality of our solution by interoperating with other standards-based products from a variety of vendors," said Patricia Katzman, strategic marketing, medical software at Aware.  "Healthcare and IT professionals will see that products are available today that enable access to patient image data across local, regional, and national health information exchanges to support meaningful, secure use of electronic health records."

About HIMSS10 Interoperability Showcase

The HIMSS10 Interoperability Showcase will incorporate the initial, proposed metrics of Meaningful Use of electronic health records and other systems as part of its real-time demonstrations.  Attendees can track their EHR and PHR through the Showcase, designed as a HIMSS HIE-based environment.  This interactive exhibit offers a realistic look at complex healthcare scenarios where different organizations and agencies incorporate interoperability into their products.  These scenarios use the standards-based Integrating the Healthcare Enterprise (IHE) framework and Specifications of the Healthcare Information Technology Standards Panel (HITSP), recognized and accepted by the Department of Health and Human Services.

Visit the HIMSS Interoperability showcase at HIMSS10 Booth #233.

About AccuRad ImageShare Platform

AccuRad ImageShare Platform is comprised of AccuRad ImageShare Workstation and AccuRad ImageShare Server, which can each be used independently, or together as a comprehensive, turnkey client/server solution. It is built upon Aware's established AccuRad SDKs, including J2KSuite, and JPIPStream.  It achieves interoperability and performance by utilizing DICOM, WADO, the web services advantages of the IHE's XDS-I.b Profile, and the advanced features of JPEG2000 compression and JPIP streaming to enable users with fast access to diagnostic quality images across multiple enterprises over constrained networks.  The AccuRad ImageShare Platform successfully passed testing at the Integrating the Healthcare Enterprise (IHE) North American Connectathon 2010 event in Chicago.  

Find out more about Aware's AccuRad ImageShare Platform at HIMSS10 Booth #6050.

About Aware

Aware is a leading technology and supplier for the telecommunications and biometrics industries. Aware has pioneered innovations at telecommunications standards-setting organizations for DSL and networking. Telecom equipment vendors and phone companies use Aware's DSL test and diagnostics modules and Dr. DSL® software to provision and troubleshoot DSL circuits globally. Aware is also a veteran of the biometrics industry, providing biometric and imaging software components used in government systems worldwide since 1992. Aware's interoperable, standard-compliant, field-proven imaging products are used in a number of applications, from border management to criminal justice to medical imaging. Aware is a publicly held company (Nasdaq: AWRE) based in Bedford, Massachusetts.

Safe Harbor Warning

Portions of this release contain forward-looking statements regarding future events and are subject to risks and uncertainties, such as estimates or projections of future revenue and earnings and the growth of the biometrics markets. Aware wishes to caution you that there are factors that could cause actual results to differ materially from the results indicated by such statements. Biometric factors include, but are not limited to: market acceptance of our biometric technologies and products; changes in contracting practices of government or law enforcement agencies; the failure of the biometrics market to experience continued growth; announcements or introductions of new technologies or products by our competitors; failures or problems in our biometric software products; delays in the adoption of new industry biometric standards; growth of proprietary biometric systems which do not conform to industry standards; our ability to sell services contracts in a manner that is consistent with our business model; our ability to deliver service contract milestones; and our dependence on third party contractors and consultants to deliver certain services contract milestones. We refer you to the documents Aware files from time to time with the Securities and Exchange Commission, specifically the section titled Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 2009 and other reports and filings made with the Securities and Exchange Commission.

Aware, AccuRad ImageShare, and Dr. DSL are trademarks or registered trademarks of Aware, Inc. Any other trademarks appearing herein are the property of their respective owners.

SOURCE Aware, Inc.

Back to top



SOURCE Aware, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Aware, Inc. Announces Support for New ITU Testing Standard with Line Diagnostics Platform
2. Aware, Inc. Reports Third Quarter 2009 Financial Results
3. Aware, Inc. Reports Third Quarter 2009 Financial Results
4. Aware, Inc. Reports Second Quarter 2009 Financial Results
5. Aware, Inc. Announces Q209 Earnings Conference Call
6. Aware, Inc. Reports First Quarter 2009 Financial Results
7. Aware, Inc. Reports First Quarter 2009 Financial Results
8. Aware, Inc. Announces Final Results of Dutch Auction Tender Offer
9. Aware, Inc. Announces Q1 09 Earnings Conference Call
10. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
11. Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
Post Your Comments:
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
Breaking Biology Technology: